#UroSome

6 days ago

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

1 0 0 0

1 week ago

Flashback to our 2019 interview day, our fellow grads from 2022: (L) Dr. Jared Schober, now at U Nebraska (R) Dr Kevin Ginzburg, now at Wayne State

Getting ready to host Fox Chase Cancer Center SUO fellowship interviews. Excited to be back in-person for the first time since these superstars!
#UroEd #UroSome

0 0 0 0

1 week ago

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

1 0 0 0

1 week ago

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

1 0 0 0

1 week ago

🤖 Is robotic surgery shaping the future of functional & reconstructive urology?
🗓 11 Mar | 18:00 CET
🎙 Dr Tim Brits & Dr Donald Vaganée

🔗 events.zoom.us/ev/Am-FtKOsm...

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #Urology #UroSoMe @jardinjointaction.bsky.social @uroweb.org

1 1 0 0

2 weeks ago

#ASCO #GU26
Day 2 —it’s urothelial cancer day!
#UroSome

0 0 3 0

1 month ago

A Cornell urology residency alum presenting the Keynote address for Philly Urologic (PUS)

Two old guys who trained together in urology starting at the end of the last century

Great to see Jaspeet Sandhu @mskcancercenter.bsky.social in town to give the Philadelphia Urologic Society B.A. Thomas lecture—a leader in urology cancer survivorship. Has it really been over 25 yrs since we were at The Brady? #CornellMafia
#UroSoMe #UroSky

1 0 0 0

1 month ago

ERN eUROGEN Webinar 140: Applicability of microRNA studies in testicular germ cell tumours YouTube video by ERN eUROGEN

🧬 Missed our webinar on microRNA studies in testicular germ cell tumours?

📺 Watch now: youtu.be/ezg8w7SkOw8

📰 Subscribe: tinyurl.com/ERNeUROGENne...

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #EUCancerPlan #EUCancerMission #UroSoMe
@ec.europa.eu @jardinjointaction.bsky.social

1 0 0 0

1 month ago

ERN eUROGEN Webinar 139: Adrenal cancer and malignant cysts This webinar was presented on the 28th of January by Prof. dr. Hans Langenhuijsen and Ass. Prof. Dr. Nikola Knežević. Prof. Langenhuijsen is a urologist, and professor in adrenal surgery at the…

🎥 Watch our webinar on Adrenal Cancer and Malignant Cysts with Hans Langenhuijsen & Nikola Knežević

📺 youtu.be/NK8dsUHF_dU

📰 tinyurl.com/ERNeUROGENne...

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #EUCancerPlan #EUCancerMission #UroSoMe @ec.europa.eu @jardinjointaction.bsky.social

1 1 0 0

1 month ago

Hey, let’s get you over here. Maybe double post here and that other place and see if we can increase the traffic to a critical mass. #UroSoMe

0 0 0 0

1 month ago

ERN eUROGEN Webinar 138: Medical Device Shortages and Regulatory Constraints: An ERN Collaboration The increasing shortage of essential medical devices, compounded by evolving regulatory frameworks, presents critical challenges for the care of patients with rare and complex conditions.…

⚠️ Missed our cross-ERN webinar on medical device shortages & regulatory barriers?

🎥 Now on YouTube: www.youtube.com/watch?v=QGvG...

📰 Subscribe: bit.ly/4j7MaHU

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroSoMe @ec.europa.eu @jardinjointaction.bsky.social

0 0 0 0

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroSoMe

2 months ago

0 0 0 0

EV-103 Cohort K: long-term outcomes of EV ± pembrolizumab in la/mUC - VJOncology Terence Friedlander, MD, University of California, San Francisco, CA, discusses updated results from Cohort K of the Phase Ib/II EV-103...

4 months ago

Terence Friedlander, MD, shares 3.5-year #EV103 Cohort K data at #ESMO25 — enfortumab vedotin + pembrolizumab continues to show durable responses & survival benefits in 1L la/mUC.

🎥 Watch: buff.ly/kWn5KkI

#UroOnc #UroSoMe #Blcsm #ImmunoOnc #CTSM #TrialUpdate

1 0 0 0

EMBARK: final OS results of enzalutamide in hrBCR prostate cancer - VJOncology Neal Shore, MD, FACS, Carolina Urologic Research Center, Myrtle Beach, SC, discusses final overall survival results from the Phase III...

4 months ago

Neal Shore, MD, FACS shares final OS data from EMBARK in high-risk BCR prostate cancer.

💊 Enzalutamide + leuprolide ↓ risk of death vs leuprolide alone
📈 Improved progression & skeletal outcomes
✅ Confirms enzalutamide-based therapy as SoC
🎥 buff.ly/LBEmrOa

#ProstateCancer #ESMO25 #UroOnc #UroSoMe

0 0 0 0

FORAGER-1: dose optimization of LY3866288 in FGFR3-altered tumors - VJOncology Alexandra Drakaki, MD, PhD, University of California, Los Angeles, CA, discusses the Phase I FORAGER-1 study (NCT05614739) of LY3866288, a...

4 months ago

Alexandra Drakaki, MD, PhD, discusses FORAGER-1 testing LY3866288 in FGFR3-altered tumors

🧬 200 mg BID = well tolerated
💥 Encouraging antitumor activity in mUC
🧪 Activity seen post-FGFR inhibitor exposure

🎥 buff.ly/ozWqgdG

#BladderCancer #Blcsm #UroOnc #UroSoMe #CTSM #TrialUpdate #ESMO25

0 0 0 0

COSMIC-313: transcriptomic predictors of metastatic sites in RCC - VJOncology Clara Steiner, MD, Dana-Farber Cancer Institute, Boston, MA & University Hospital Leipzig, Leipzig, Germany, discusses a post-hoc transcriptomic analysis from...

4 months ago

Clara Steiner, MD, presents new transcriptomic findings from COSMIC-313 in #RCC at #ESMO25

🧬 RNA sequencing of baseline tumors
🔍 Distinct gene signatures by metastasis site
🌡️ Pathways: metabolism, hypoxia, EMT

🎥 Watch: buff.ly/dIMvnoC

@myesmo.bsky.social #KCSM #CTSM #TrialUpdate #UroOnc #UroSoMe

0 0 0 0

4 months ago

ERN eUROGEN Webinar 134: Interstitial Cystitis: Multidisciplinary management of complex BPS This webinar was presented on 22 October by Dr. Lisa Moris, who is a urologist at the University Hospital in Leuven, Belgium. Her research interests are: ketamine induced uropathy, bladder pain…

🧠 Missed our webinar on Interstitial Cystitis & Complex Bladder Pain Syndrome? Dr. Lisa Moris shares a multidisciplinary approach.

📺 youtu.be/C9yFFx06I24
📰 bit.ly/4j7MaHU

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #FPMRS #UroSoMe

1 0 0 0

PSMAddition: 177Lu-PSMA-617 plus ADT and ARPI in PSMA-positive mHSPC - VJOncology Scott Tagawa, MD, MS, FACP, Weill Cornell Medical Center, New York, NY, discusses the Phase III PSMAddition trial (NCT04720157), which...

4 months ago

At #ESMO25, Scott Tagawa, MD, MS, FACP, discusses the Phase III PSMAddition trial in PSMA-positive mHSPC:

💥 Adding ¹⁷⁷Lu-PSMA-617 to ADT + ARPI improved rPFS
📈 OS trend & manageable safety
✅ No major QoL impact

🎥 Watch: buff.ly/vSBfVPS

@myesmo.bsky.social #PCSM #UroOnc #UroSoMe #RadOnc #CTSM

0 0 0 0

CheckMate 274: 5-year results of adjuvant nivolumab in MIUC - VJOncology Clara Steiner, MD, Dana-Farber Cancer Institute, Boston, MA & University Hospital Leipzig, Leipzig, Germany, gives an overview of updated 5-year...

4 months ago

At #ESMO25, Clara Steiner, MD, presents 5-year results of CheckMate 274 in MIUC

💊 Adjuvant nivolumab vs placebo after surgery
📈 Sustained DFS, OS & disease-specific survival benefit
🧫 ctDNA-positive pts saw enhanced benefit
✅ No new safety concerns

🎥 Watch: buff.ly/ou4EvLv

#UroOnc #UroSoMe #Blcsm

0 0 0 0

RENALUT: 177Lu-PSMA-617 in metastatic pre-treated ccRCC - VJOncology Emmanuel Seront, MD, PhD, Cliniques Universitaires Saint Luc, Brussels, Belgium, discusses the Phase II RENALUT (NCT06783348) of 177Lu-PSMA-617 in patients...

4 months ago

At #ESMO25, Emmanuel Seront discusses the RENALUT trial of ¹⁷⁷Lu-PSMA-617 in metastatic ccRCC

💥 PSMA-targeted radioligand therapy after TKI + ICI progression
🎯 Evaluating response, PFS, OS, & safety
🧠 Imaging-guided treatment w/ added cycles for responders

🎥 buff.ly/sswLUyk

#kcms #UroOnc #UroSoME

1 0 0 0

Fennec Pharmaceuticals

@fennecpharma.com

5 months ago

Our team joined the Testicular Cancer Awareness Foundation for the 10th Annual Testicular Cancer Conference in Boston. It was an inspiring weekend with survivors, patients, caregivers, medical experts, and researchers.

#TesticularCancer #UroSoMe #urology #MensHealth #TCAF

1 0 0 0

RAISN: indocyanine green-guided lymph node dissection in testicular cancer - VJOncology Yue Che, MD, University Hospital of Duesseldorf, Düsseldorf, Germany, discusses the evolving role of retroperitoneal lymph node dissection and therapy...

5 months ago

⭐ Yue Che, MD, shares RAISN trial: ICG-guided sentinel node biopsy is feasible & well tolerated in stage I testicular cancer, aiming to reduce chemo use:

🎥 buff.ly/kF09jHH

#EAU25 #UroOnc #UroSoMe #CTSM #TrialUpdate #TSCsm

1 0 0 0

5 months ago

🚨 TONIGHT! Join us for a cutting-edge webinar on Stage II Testicular Germ Cell Tumours

👨‍⚕️Dr Arnout Alberts shares the latest in personalised, multidisciplinary care
📅 Wed 1 Oct @ 17:00 CEST
🎓 EACCME-accredited
🔗 bit.ly/eUROGEN01Oct25

#EUfunded #EU4Health #RareDisease #ERNs #UroOnc #UroSoMe

1 1 0 0

5 months ago

Join us for a cutting-edge webinar on Stage II Testicular Germ Cell Tumours 💥

👨‍⚕️Dr Arnout Alberts shares the latest in personalised, multidisciplinary care
📅 Wed 1 Oct @ 17:00 CEST
🎓 EACCME-accredited
🔗 bit.ly/eUROGEN01Oct25

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroOnc #UroSoMe

0 0 1 0

Updates in the PROBASE study of risk adapted screening for prostate cancer - VJOncology Peter Albers, German Cancer Research Center (DKFZ), Heidelberg & Heinrich-Heine-University, Düsseldorf, Germany, comments on the PROBASE trial of risk adapted...

5 months ago

🎥 Peter Albers, MD, comments on PROBASE: men with negative biopsy unlikely to develop prostate cancer within 5 yrs. Doubling PSA values key to refining high-risk group & avoiding overdiagnosis.

➡️ buff.ly/4gKsdFN

#EAU25 #UroOnc #UroSoMe #PCSM #CTSM #TrialUpdate

0 0 0 0

5 months ago

Join us for a cutting-edge webinar on Stage II Testicular Germ Cell Tumours 💥

👨‍⚕️Dr Arnout Alberts shares the latest in personalised, multidisciplinary care
📅 Wed 1 Oct @ 17:00 CEST
🎓 EACCME-accredited
🔗 bit.ly/eUROGEN01Oct25

#EUfunded #EU4Health #HealthUnion #RareDisease #ERNs #UroOnc #UroSoMe

1 0 1 0